Characteristics and Surgical Outcomes in Very Elderly Patients (≥75 years) with Renal Cell Carcinoma: Data from the Latin American Renal Cancer Group
Rev. invest. clín
; Rev. invest. clín;72(5): 308-315, Sep.-Oct. 2020. tab
Article
en En
| LILACS, UY-BNMED, BNUY
| ID: biblio-1289722
Biblioteca responsable:
UY1.1
ABSTRACT
Background:
The incidence of renal cell carcinoma (RCC) is increasing globally due to an aging population and widespread use of imaging studies.Objective:
The aim of this study was to describe the characteristics and perioperative outcomes of RCC surgery in very elderly patients (VEP), ≥75 years of age.Methods:
This is a retrospective comparative study of 3656 patients who underwent the treatment for RCC from 1990 to 2015 in 28 centers from eight Latin American countries. We compared baseline characteristics as well as clinical and perioperative outcomes according to age groups (<75 vs.≥ 75 years). Surgical complications were classified with the Clavien-Dindo score. We performed logistic regression analysis to identify factors associated with perioperative complications.Results:
There were 410 VEP patients (11.2%). On bivariate analysis, VEP had a lower body mass index (p < 0.01) and higher ASA score (ASA >2 in 26.3% vs. 12.4%, p < 0.01). There was no difference in performance status and clinical stage between the study groups. There were no differences in surgical margins, estimated blood loss (EBL), complication, and mortality rates (1.3% vs. 0.4%, p = 0.17). On multivariate regression analysis, age ≥75 years (odds ratio [OR] 2.33, p < 0.01), EBL ≥ 500 cc (OR 3.34, p < 0.01), and > pT2 stage (OR 1.63, p = 0.04) were independently associated with perioperative complications.Conclusions:
Surgical resection of RCC was safe and successful in VEP. Age ≥75 years was independently associated with 30-day perioperative complications. However, the vast majority were low-grade complications. Age alone should not guide decision-making in these patients, and treatment must be tailored according to performance status and severity of comorbidities. (REV INVEST CLIN. 2020;72(5)308-15)Palabras clave
Texto completo:
1
Banco de datos:
BNUY
/
LILACS
/
UY-BNMED
Asunto principal:
Carcinoma de Células Renales
Tipo de estudio:
Prognostic_studies
Límite:
Aged
/
Aged80
/
Humans
Idioma:
En
Revista:
Rev. invest. clín
Asunto de la revista:
MEDICINA
Año:
2020
Tipo del documento:
Article
País de afiliación:
Argentina
/
Brasil
/
México
/
Perú
/
España
/
Uruguay